Brazilian researchers map cancer protein to unlock future treatments
NCT ID NCT07101081
Summary
This study aims to understand how common a specific protein called HER2 is in five types of gynecological cancers. Researchers will analyze stored tumor tissue samples from 350 adult patients in Brazil to measure HER2 levels. The goal is to gather information that could help guide the development of future targeted treatments for these cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GYNAECOLOGICAL CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oncoclínicas Precision Medicine
São Paulo, São Paulo, Brazil
Conditions
Explore the condition pages connected to this study.